Comparison of Decolonization of Methicillin-resistant Staphylococcus Aureus (MRSA) Using Theraworx (SJMRSA)

Mercy Research

Status: Withdrawn

Conditions: Methicillin-Resistant Staphylococcus Aureus

Treatments: Drug: mupirocin antibiotic ointment; Other: Theraworx

Study type: Interventional

Funder types: Other

Identifiers

NCT00713674

SJMRSA-01

Details and patient eligibility

About

The purpose of this study is to examine treatment method of Methicillin-resistant Staphylococcus aureus (MRSA) decolonization in patients.

Full description

Decolonization therapy is indicated for management of patients with MRSA. Theraworx is reported to be an effective antimicrobial against multiple organisms. In this study, patients with positive MRSA colonization culture will be treated with Theraworx to evaluate decolonization duration capability.

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Positive MRSA culture

Exclusion criteria

• Patients currently on or start antibiotic therapy directed for MRSA.(Prophylaxis antibiotic for surgical procedure not considered therapy.)
• Patients with MRSA infected wounds
• Patients under the age of 18 years
• A woman currently pregnant or nursing a child
• Patients participating in another study within 30 days of randomization

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

0 participants in 3 patient groups

1

No Intervention group

Description:

No Treatment

2

Experimental group

Description:

Theraworx intranasal

Treatment:

Other: Theraworx

3

Active Comparator group

Description:

mupirocin antibiotic ointment intranasal

Treatment:

Drug: mupirocin antibiotic ointment